(Q40905330)

English

The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

author name string

Hübinger G

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Scheffrahn I

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Müller E

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Bai R

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Duyster J

5

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Morris SW

6

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Schrezenmeier H

7

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Bergmann L

8

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Experimental Hematology

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

1796-1805

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Updated Kiel classification for lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Ki-1 (CD30) anaplastic large-cell lymphoma in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5)

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel domain in the CD30 cytoplasmic tail mediates NFkappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired Negative Selection of T Cells in Hodgkin's Disease Antigen CD30–Deficient Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Opposite effects of the CD30 ligand are not due to CD30 mutations: results from cDNA cloning and sequence comparison of the CD30 antigen from different sources

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated p

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900116-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0301-472X(99)00116-2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40905330&oldid=1909932602"